-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Influenza Virus
CAS No. | Product Name | Inquiry |
---|---|---|
157-03-9 |
6-Diazo-5-oxo-L-nor-LeucineIt is produced by the strain of Streptomyces ambofaciens. It has anti-tumor activity and is not suitable for clinical use due to excessive toxicity. Its N-acetyl (Duazomycin) also has anti-tumor effect. |
|
160003-66-7 |
IniparibBSI-201 is a small-molecule prodrug inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase-1 (PARP-1) with potential chemosensitizing, radiosensitizing and antineoplastic activities. In vivo, PARP-1 inhibitor BSI-201 is converted to the active drug, which selectively binds to PARP-1 and inhibits PARP-1- mediated DNA repair. Consequently, this agent may enhance the cytotoxicity of DNA-damaging agents and reverse tumor cell resistance to chemotherapy and radiation therapy. In addition, PARP-1 inhibitor BSI-201 may exhibit direct antineoplastic activity against cancers defective in DNA repair. PARP-1 catalyzes post-translational ADP-ribosylation of nuclear proteins and is activated by single-strand DNA (ssDNA) breaks. |
|
162666-34-4 |
Flutimide |
|
1627115-50-7 |
Influenza virus-IN-8 |
|
1629869-44-8 |
VX-787VX-787, a pyrrolopyridine derivative, has been found to be an antiviral agent and is still under Phase II trial against Influenza A virus infection. |
|
1638211-04-7 |
ML303ML303 is an antagonist of pyrazolopyridine influenza virus nonstructural protein 1 (NS1). |
|
1644156-41-1 |
DHODH-IN-9DHODH-IN-9, an azine-bearing analogue, is a human dihydroorotate dehydrogenase inhibitor with antiviral effect (pMIC50 = 7.4). |
|
1644156-56-8 |
hDHODH-IN-4hDHODH-IN-4 is a potent inhibitor of human dihydroorotate dehydrogenase (DHODH), with a pIC50 of 7.8 for human recombinant DHODH. It inhibits measles virus replication, with a pMIC50 of 8.8. |
|
1644156-80-8 |
hDHODH-IN-3hDHODH-IN-3, a human dihydroorotate dehydrogenase inhibitor, inhibits measles virus replication with a pMIC50 of 8.6. |
|
170380-69-5 |
1,4-Epidioxybisabola-2,10-dien-9-one1,4-Epidioxybisabola-2,10-dien-9-one is isolated from the leaves of Alpinia intermedia. |
|
171094-50-1 |
Zanamivir-hydrate(5:1)Zanamivir hydrate (5:1) is the hydrate of Zanamivir. Zanamivir is an influenza viral neuraminidase inhibitor with IC50 valuesof 0.95 nM and 2.7 nM for influenza A and B, respectively |
|
174605-64-2 |
L-742001 Hydrochloride |
|
175669-29-1 |
Polycarpine hydrochloride |
|
1777807-64-3 |
ZINC03129319ZINC03129319, an activator of stimulator of interferon genes (STING), is a dengue virus (DENV) NS2B-NS3 protease inhibitor with inhibition constants (Ki1) of 92 μM and Ki3 of 20 μM. (Extracted from patent US20150141521A1) |
|
1795138-23-6 |
Ketotifen-d3 FumarateKetotifen-[d3] fumarate is the labelled salt of Ketotifen, which is a second-generation noncompetitive H1-antihistamine and mast cell stabilizer. Ketotifen is used as an antiasthmatic and antiallergic agent. |
|
1807887-16-6 |
Antiviral-agent-19Antiviral agent 19 (Compound 3) is a selective inhibitor against Zika virus infection with an EC50 of 1.3 µM. |
|
1807954-17-1 |
Gedivumab |
|
1807960-57-1 |
Lesofavumab |
|
18133-22-7 |
Netropsin DihydrochlorideIt is a basic cytotoxic polypeptide produced by the strain of Streptomyces netropsis. It is a DNA minor groove binding ligand. |
|
181373-35-3 |
NS1-IN-1NS1-IN-1 (compound 3) is a potent NS1 inhibitor. NS1 is a major influenza A virus virulence factor that inhibits host gene expression. NS1-IN-1 decreases viral protein levels, contributing to the reduction of virus replication. NS1-IN-1 shows antiviral activity by repressing the activity of mTORC1 in a TSC1-TSC2-dependent manner. |
※ Please kindly note that our services are for research use only.